1357475

拉坦前列素

United States Pharmacopeia (USP) Reference Standard

• 同義詞: 异丙基 (5Z,9α,11α,15R)-9,11,15-三羟基-17-苯基-18,19,20-三硝基苯-5-烯-1-酸酯, 异丙基 ( Z )-7-[(1 R ,2 R ,3 R ,5 S )-3,5-二羟基-2-[(3 R )-3-羟基-5-苯戊基] 环戊基] 庚烯-5-酸酯, 适利达
• 經驗公式（希爾表示法）: C₂₆H₄₀O₅
• CAS號碼: 130209-82-4
• 分子量：: 432.59
• MDL號碼: MFCD00216074
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329750242
• NACRES: NA.24

屬性

• 等級: pharmaceutical primary standard
• API 家族: latanoprost
• 製造商／商標名: USP
• 應用: pharmaceutical (small molecule)
• 形式: neat
• 儲存溫度: −20°C
• SMILES 字串: CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2
• InChI: 1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1
• InChI 密鑰: GGXICVAJURFBLW-CEYXHVGTSA-N
• 基因資訊: human ... PTGFR(5737)

描述

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Latanoprost USP reference standard for use in specified quality tests and assays.

Also used to prepare standard and system-suitability solutions for assay and impurity analysis according to the given below monographs of United States Pharmacopeia (USP):

• Latanoprost Compounded Topical Solution
• Latanoprost

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

免責聲明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS08
• 訊號詞: Warning
• 危險聲明: H361d
• 防範說明: P201 - P202 - P280 - P308 + P313 - P405 - P501
• 危險分類: Repr. 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable